Related Experiment Video
Updated: Jun 29, 2025
07:39
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
23.9K
Targeting Senescence for Next-Generation Cancer Treatments
Eric Gilson1,2,3, Pierre Soubeyran4,5, Eric Solary6,7
1Université Côte d'Azur, CNRS, Inserm, IRCAN, Faculté de Médecine, Nice, France.
Cancer Discovery
|April 4, 2024
Summary
Cellular senescence plays a complex role in cancer development and treatment. Understanding its dual effects is key to developing effective cancer therapies by overcoming key challenges in manipulating senescence.
Area of Science:
- Oncology
- Cell Biology
- Aging Research
Background:
- Cellular senescence, a state of irreversible cell cycle arrest, exhibits complex and often contradictory roles in cancer.
- Senescence can suppress tumor initiation but also promote cancer progression and treatment resistance.
Purpose of the Study:
- To elucidate the multifaceted interactions between cellular senescence and cancer.
- To identify critical challenges and lessons learned in therapeutically targeting senescence for cancer prevention and cure.
Main Methods:
- Review and synthesis of existing research on cellular senescence and cancer.
- Analysis of the dual roles of senescence in cancer emergence, progression, and therapeutic response.
Main Results:
- Identified four key lessons from studying the interplay of senescence and cancer.
- Highlighted four significant bottlenecks hindering the effective therapeutic manipulation of cellular senescence.
Conclusions:
- Cellular senescence presents both opportunities and obstacles in cancer therapy.
- Addressing the identified bottlenecks is crucial for advancing senescence-based cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:15Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K